\-\ Texto\\:\\ \ \(0\)\
\-\ afebrile\\.\\ left\\ eye\\ has\\ periorbital\\ swelling\\ with\\ palpable\\ mass\\ on\\ medial\\ canthus\\.\\ no\\ discharge\\.\ \(0\)\
\-\ due\\ to\\ significant\\ swelling\\ around\\ the\\ eye\\,\\ treatment\\ for\\ this\\ patient\\ included\\ iv\\ and\\ topical\\ antibiotics\\,\\ probing\\,\\ drainage\\ and\\ surgical\\ marsupialization\\ under\\ general\\ anesthesia\\.\ \(0\)\
\-\ a\\ cystic\\ mass\\ \\ located\\ anteromedial\\ to\\ left\\ globe\ \(0\)\
\-\ dacryocystocele\\ with\\ dacryocystitis\\ and\\ periorbital\\ cellulitis\ \(0\)\
\-\ \\â\\€\\¢\\	dacryocystocele\\ with\\ or\\ without\\ dacryocystitis\\ \ \(0\)\
\-\ \\â\\€\\¢\\	periorbital\\ cellulitis\\ \ \(0\)\
\-\ \\â\\€\\¢\\	orbital\\ cellulitis\\ \ \(0\)\
\-\ \\â\\€\\¢\\	meningocele\\ \ \(0\)\
\-\ \\â\\€\\¢\\	encephalomeningocele\\ \ \(0\)\
\-\ \\â\\€\\¢\\	hemangioma\\ \ \(0\)\
\-\ \\â\\€\\¢\\	dermoid\\ cyst\ \(0\)\
\-\ \\â\\€\\¢\\	glioma\ \(0\)\
\-\ a\\ 4\\ month\\-old\\ boy\\ presents\\ with\\ left\\ eye\\ swelling\\ for\\ about\\ 48hours\\ that\\ started\\ with\\ dark\\ discoloration\\ on\\ left\\ lower\\ lid\\.\\ no\\ history\\ of\\ trauma\\.\ \(0\)\
\-\ a\\ dacryocystocele\\ is\\ a\\ grey\\-blue\\ cystic\\ swelling\\ often\\ filled\\ with\\ mucoid\\ material\\ below\\ the\\ medial\\ canthus\\.\\ \\ it\\ is\\ a\\ rare\\ complication\\ of\\ congenital\\ nasolacrimal\\ duct\\ obstruction\\.\\ it\\ often\\ results\\ from\\ incomplete\\ canalization\\ of\\ the\\ lower\\ part\\ of\\ the\\ nasolacrimal\\ duct\\ at\\ the\\ valve\\ of\\ hasner\\ \\(anatomical\\)\\ and\\ secondary\\ obstruction\\ proximally\\ at\\ the\\ rosenmuller\\ valve\\ from\\ distension\\ of\\ the\\ sac\\ and\\ compression\\ of\\ the\\ canal\\ system\\ \\(functional\\)\\.\ \(0\)\
\-\ \\ \\ \\ \\ \\ incidence\\ of\\ imperforate\\ nld\\ in\\ full\\-term\\ fetuses\\ is\\ 35\\-73\\%\\ with\\ spontaneous\\ resolution\\ in\\ about\\ 85\\-95\\%\\ of\\ patients\\ by\\ age\\ 1\\.\\ \\ it\\ is\\ more\\ common\\ in\\ females\\ and\\ often\\ presents\\ unilaterally\\.\\ \\ complications\\ include\\ dacryocystitis\\,\\ cellulitis\\,\\ astigmatism\\,\\ narrowing\\ of\\ lid\\ fissure\\ and\\ respiratory\\ difficulty\\ from\\ mass\\ effect\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ dacryocystocele\\:\\ 0\\.30336337413916803\ \(0\)\
\-\ dacryocystitis\\:\\ 0\\.30336337413916803\ \(0\)\
\-\ cellulitis\\:\\ 0\\.27780702414636593\ \(0\)\
\-\ periorbital\\:\\ 0\\.23099645251629486\ \(0\)\
\-\ swelling\\:\\ 0\\.17815005832685987\ \(0\)\
\-\ canthus\\:\\ 0\\.1767536145228051\ \(0\)\
\-\ nasolacrimal\\:\\ 0\\.1720979028170601\ \(0\)\
\-\ lid\\:\\ 0\\.16340473177575385\ \(0\)\
\-\ eye\\:\\ 0\\.15881126046034083\ \(0\)\
\-\ often\\:\\ 0\\.12953319458413767\ \(0\)\
\-\ of\\:\\ 0\\.1294971917474766\ \(0\)\
\-\ valve\\:\\ 0\\.12135617569672273\ \(0\)\
\-\ duct\\:\\ 0\\.11392480440690697\ \(0\)\
\-\ 48hours\\:\\ 0\\.1058246730955013\ \(0\)\
\-\ hasner\\:\\ 0\\.1058246730955013\ \(0\)\
\-\ nld\\:\\ 0\\.1058246730955013\ \(0\)\
\-\ the\\:\\ 0\\.1056309309043589\ \(0\)\
\-\ it\\:\\ 0\\.10161875591957908\ \(0\)\
\-\ encephalomeningocele\\:\\ 0\\.101121124713056\ \(0\)\
\-\ canalization\\:\\ 0\\.101121124713056\ \(0\)\
\-\ astigmatism\\:\\ 0\\.101121124713056\ \(0\)\
\-\ about\\:\\ 0\\.09907857922208888\ \(0\)\
\-\ marsupialization\\:\\ 0\\.09778390402629317\ \(0\)\
\-\ rosenmuller\\:\\ 0\\.09778390402629317\ \(0\)\
\-\ fetuses\\:\\ 0\\.09778390402629317\ \(0\)\
\-\ unilaterally\\:\\ 0\\.09778390402629317\ \(0\)\
\-\ and\\:\\ 0\\.09571655663801636\ \(0\)\
\-\ probing\\:\\ 0\\.09519535455841378\ \(0\)\
\-\ obstruction\\:\\ 0\\.09270056430763458\ \(0\)\
\-\ mucoid\\:\\ 0\\.09129214954113946\ \(0\)\
\-\ with\\:\\ 0\\.09070219640208176\ \(0\)\
\-\ left\\:\\ 0\\.09029190713708926\ \(0\)\
\-\ imperforate\\:\\ 0\\.08837680726140255\ \(0\)\
\-\ medial\\:\\ 0\\.08614691553664575\ \(0\)\
\-\ discoloration\\:\\ 0\\.08503958657463974\ \(0\)\
\-\ meningocele\\:\\ 0\\.08170236588787692\ \(0\)\
\-\ cystic\\:\\ 0\\.0797072224254096\ \(0\)\
\-\ from\\:\\ 0\\.07884306239872983\ \(0\)\
\-\ topical\\:\\ 0\\.07854783208948603\ \(0\)\
\-\ anteromedial\\:\\ 0\\.07699881750543162\ \(0\)\
\-\ anesthesia\\:\\ 0\\.07607029186740318\ \(0\)\
\-\ mass\\:\\ 0\\.07582870066921339\ \(0\)\
\-\ proximally\\:\\ 0\\.07480353884028675\ \(0\)\
\-\ anatomical\\:\\ 0\\.07366159681866881\ \(0\)\
\-\ is\\:\\ 0\\.07248745605877993\ \(0\)\
\-\ globe\\:\\ 0\\.0689580484362235\ \(0\)\
\-\ distension\\:\\ 0\\.06871885691756949\ \(0\)\
\-\ lower\\:\\ 0\\.06762872064878112\ \(0\)\
\-\ females\\:\\ 0\\.06656446788820858\ \(0\)\
\-\ dark\\:\\ 0\\.0649175592408299\ \(0\)\
\-\ incomplete\\:\\ 0\\.0649175592408299\ \(0\)\
\-\ functional\\:\\ 0\\.0649175592408299\ \(0\)\
\-\ fissure\\:\\ 0\\.06458129286563569\ \(0\)\
\-\ presents\\:\\ 0\\.0636650409636443\ \(0\)\
\-\ complication\\:\\ 0\\.06010083554449079\ \(0\)\
\-\ discharge\\:\\ 0\\.05933809473302628\ \(0\)\
\-\ part\\:\\ 0\\.05912907326430696\ \(0\)\
\-\ sac\\:\\ 0\\.058923751485512516\ \(0\)\
\-\ orbital\\:\\ 0\\.05804228626764892\ \(0\)\
\-\ spontaneous\\:\\ 0\\.057580058680252566\ \(0\)\
\-\ included\\:\\ 0\\.05722309581846037\ \(0\)\
\-\ afebrile\\:\\ 0\\.0571355453828041\ \(0\)\
\-\ incidence\\:\\ 0\\.056962402203453485\ \(0\)\
\-\ glioma\\:\\ 0\\.05621373098457007\ \(0\)\
\-\ dermoid\\:\\ 0\\.05589589253646176\ \(0\)\
\-\ started\\:\\ 0\\.055740180431256565\ \(0\)\
\-\ material\\:\\ 0\\.055740180431256565\ \(0\)\
\-\ hemangioma\\:\\ 0\\.05566310122633484\ \(0\)\
\-\ difficulty\\:\\ 0\\.05566310122633484\ \(0\)\
\-\ under\\:\\ 0\\.05477601612414927\ \(0\)\
\-\ below\\:\\ 0\\.05449478107360481\ \(0\)\
\-\ resolution\\:\\ 0\\.05368980774323123\ \(0\)\
\-\ filled\\:\\ 0\\.05324480718850407\ \(0\)\
\-\ general\\:\\ 0\\.053120737795555366\ \(0\)\
\-\ drainage\\:\\ 0\\.052997981330870296\ \(0\)\
\-\ around\\:\\ 0\\.05281624846015268\ \(0\)\
\-\ respiratory\\:\\ 0\\.052637318779153244\ \(0\)\
\-\ located\\:\\ 0\\.052345102379365384\ \(0\)\
\-\ results\\:\\ 0\\.05156401275747094\ \(0\)\
\-\ narrowing\\:\\ 0\\.05129732566381815\ \(0\)\
\-\ canal\\:\\ 0\\.05093397316944301\ \(0\)\
\-\ complications\\:\\ 0\\.050681231632662374\ \(0\)\
\-\ system\\:\\ 0\\.05048292974979232\ \(0\)\
\-\ at\\:\\ 0\\.04998858969297093\ \(0\)\
\-\ rare\\:\\ 0\\.049954456778275945\ \(0\)\
\-\ in\\:\\ 0\\.04938491653073667\ \(0\)\
\-\ antibiotics\\:\\ 0\\.048751036270585385\ \(0\)\
\-\ compression\\:\\ 0\\.048458398613324544\ \(0\)\
\-\ congenital\\:\\ 0\\.04754576172954157\ \(0\)\
\-\ iv\\:\\ 0\\.047281676687040544\ \(0\)\
\-\ palpable\\:\\ 0\\.04648879577157115\ \(0\)\
\-\ effect\\:\\ 0\\.046419332224723164\ \(0\)\
\-\ boy\\:\\ 0\\.045266573999374234\ \(0\)\
\-\ no\\:\\ 0\\.04303726694238608\ \(0\)\
\-\ age\\:\\ 0\\.04154392325208893\ \(0\)\
\-\ for\\:\\ 0\\.04011292050112256\ \(0\)\
\-\ on\\:\\ 0\\.039970627780810855\ \(0\)\
\-\ include\\:\\ 0\\.039372198661353275\ \(0\)\
\-\ secondary\\:\\ 0\\.039222272468987844\ \(0\)\
\-\ trauma\\:\\ 0\\.03843062178137692\ \(0\)\
\-\ significant\\:\\ 0\\.03820670256532612\ \(0\)\
\-\ cyst\\:\\ 0\\.03817263388397813\ \(0\)\
\-\ due\\:\\ 0\\.038037350978642394\ \(0\)\
\-\ common\\:\\ 0\\.03752754292092082\ \(0\)\
\-\ patients\\:\\ 0\\.03722580493016611\ \(0\)\
\-\ more\\:\\ 0\\.03633593114850832\ \(0\)\
\-\ without\\:\\ 0\\.03490365090963306\ \(0\)\
\-\ to\\:\\ 0\\.03308612753837795\ \(0\)\
\-\ surgical\\:\\ 0\\.03216212721186471\ \(0\)\
\-\ treatment\\:\\ 0\\.031521603976846904\ \(0\)\
\-\ has\\:\\ 0\\.03022579551146955\ \(0\)\
\-\ that\\:\\ 0\\.02871650277210899\ \(0\)\
\-\ by\\:\\ 0\\.028100798117724354\ \(0\)\
\-\ history\\:\\ 0\\.02528183084368367\ \(0\)\
\-\ or\\:\\ 0\\.023020330128216242\ \(0\)\
\-\ this\\:\\ 0\\.02273815716740126\ \(0\)\
\-\ patient\\:\\ 0\\.02152268176216453\ \(0\)\
